CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-02 | FOEHR MATTHEW W Director | Purchase | +45,000 | $2.47 | $111K | 111,250 |
| 2022-01-15 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −827 | $4.24 | $4K | 238,695 |
| 2022-01-04 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −8,835 | $4.62 | $41K | 136,304 |
| 2022-01-04 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −11,845 | $4.62 | $55K | 239,522 |
| 2022-01-04 | Lian Brian President & CEO | Shares withheld for taxes | −26,432 | $4.62 | $122K | 2,036,686 |
| 2022-01-03 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −3,097 | $4.88 | $15K | 91,806 |
| 2022-01-03 | ZANTE GREG Chief Financial Officer | Grant or award | +53,333 | 145,139 | ||
| 2022-01-03 | ZANTE GREG Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2022-01-03 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −3,919 | $4.88 | $19K | 174,034 |
| 2022-01-03 | Mancini Marianna Chief Operating Officer | Grant or award | +77,333 | 251,367 | ||
| 2022-01-03 | Mancini Marianna Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +174,000 | 174,000 | ||
| 2022-01-03 | Lian Brian President & CEO | Shares withheld for taxes | −36,319 | $4.88 | $177K | 1,889,785 |
| 2022-01-03 | Lian Brian President & CEO | Grant or award | +173,333 | 2,063,118 | ||
| 2022-01-03 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2022-01-03 | SINGLETON J MATTHEW Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-01-03 | Rowland Charles A Jr Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-01-03 | Rouan Sarah Kathryn Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-01-03 | MACARTNEY LAWSON Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-01-03 | FOEHR MATTHEW W Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2021-09-28 | Lian Brian President & CEO | Grant or award | +55,500 | 1,952,557 |
Page 19 of 27 · 528 trades